Literature DB >> 1678400

Mechanism of killing of pneumococci by lysozyme.

J D Coonrod1, R Varble, K Yoneda.   

Abstract

Lysozyme is abundant in respiratory secretions and may play a role in lung host defenses. Mechanisms by which lysozyme killed Streptococcus pneumoniae, an important respiratory pathogen, were studied. Lysozyme caused optical clearing of pneumococcal suspensions and released fragments containing [3H]choline from their cell walls. Electron micrographs revealed wide-spread cell wall destruction and bacteriolysis. Breakdown of the cell wall appeared to be mediated mostly by the major pneumococcal autolysin, N-acetylmuramoyl-L-alanine amidase, because it was blocked by phosphorylcholine, a specific inhibitor of amidase, or by substitution of ethanolamine for choline in the cell wall. Blockade of amidase did not greatly increase survival of lysozyme-treated pneumococci on blood agar. Pneumococci in which amidase was blocked appeared intact immediately after treatment with lysozyme, but when they were reincubated at 37 degrees C in fresh culture medium they swelled and lysed. Thus, widespread triggering of the major pneumococcal autolysin is not essential for the bactericidal effect of lysozyme.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1678400     DOI: 10.1093/infdis/164.3.527

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Regulation of antimicrobial resistance by extracytoplasmic function (ECF) sigma factors.

Authors:  Emily C Woods; Shonna M McBride
Journal:  Microbes Infect       Date:  2017-01-30       Impact factor: 2.700

Review 2.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.

Authors:  W T Jansen; J Gootjes; M Zelle; D V Madore; J Verhoef; H Snippe; A F Verheul
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

4.  Modification of Pseudomonas aeruginosa interactions with corneal epithelial cells by human tear fluid.

Authors:  Suzanne M J Fleiszig; Mary S F Kwong; David J Evans
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

5.  Lysozyme as a regulator of interleukin-2-activated lymphocyte proliferation.

Authors:  N Yabe; K Komiya; T Takezono; H Matsui
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-10       Impact factor: 2.416

6.  Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae.

Authors:  Katie L Propst-Graham; Laurel C Preheim; Elizabeth A Vander Top; Mary U Snitily; Martha J Gentry-Nielsen
Journal:  BMC Microbiol       Date:  2007-10-23       Impact factor: 3.605

7.  A complex of equine lysozyme and oleic acid with bactericidal activity against Streptococcus pneumoniae.

Authors:  Emily A Clementi; Kristina R Wilhelm; Jürgen Schleucher; Ludmilla A Morozova-Roche; Anders P Hakansson
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

8.  Quantitative Proteomics of Cerebrospinal Fluid in Paediatric Pneumococcal Meningitis.

Authors:  Guadalupe Gómez-Baena; Richard J Bennett; Carmen Martínez-Rodríguez; Małgorzata Wnęk; Gavin Laing; Graeme Hickey; Lynn McLean; Robert J Beynon; Enitan D Carrol
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.